Dividend Investing Ideas Center
Have you ever wished for the safety of bonds, but the return potential...
Mike Deane Feb 02, 2015
Before Monday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.
Morgan Stanley Downgrades Cardinal Health
Cardinal Health (CAH ) was downgraded to “Equal-weight” at Morgan Stanley, due to a valuation call and price target of $86. Morgan Stanley’s $86 price target on CAH, suggests a 3% upside to the stock’s current price. CAH has dividend yield of 1.65%.
Keybanc Downgrades Crane
Crane Co. (CR ) was downgraded to “Hold” from “Buy” at Keybanc, based on a valuation call. Crane has a dividend yield of 2.17%.
Jefferies Downgrades Nabors Industries
Nabors Industries Liquid error: internal was downgraded to “Underperform” from “Hold” at Jefferies, due to lower oil prices. Jefferies has a price target of $8 on NBR, suggesting a 30% downside to the stock’s current price. NBR has a yield of 1.39%.
Telsey Downgrades Staples
Staples Liquid error: internal was downgraded to “Underperform” from “Market Perform” at Telsey Advisory, based on a valuation call, as the analyst firm believes Staples’ stock price already factors in activist action. Telsey has an $18 price target on Staples, suggesting the stock will rise 6% from its current price. SPLS has a yield of 2.82%,
Deutsche Bank Downgrades Wyndham Worldwide
Wyndham Worldwide Liquid error: internal was downgraded to “Sell” from “Hold” at Deutsche Bank, due to WYN’s multiple negative catalysts. DB has a price target of $69 on WYN, suggesting an 18% downside to the stock’s current price. WYN has a yield of 1.67%.
Morgan Stanley Cuts Numbers on AbbVie
AbbVie Inc. (ABBV ) had its price target and estimates cut as Morgan Stanley, as the company is seeing lower sales for its hepatitis-C vaccine. MS now has a price target of $65 on ABBV, suggesting an 8% upside. ABBV has a yield of 3.25%.
Credit Suisse Lowers Numbers on Avon Products
Avon Products Liquid error: internal had its price target and estimates lowered at Credit Suisse, due to the company’s lower sales expectations. Credit Suisse now has a $9 price target on AVP, suggesting a 16% upside to the stock’s price. AVP has a yield of 3.1%.